Transcatheter aortic valve replacement (TAVR) has emerged as a revolutionary treatment for aortic stenosis. However, TAVR prices vary considerably, and factors associated with this variation remain unclear. We aim to describe the variation in TAVR prices in relation to hospital financial performance among institutions ranked by the U.S. News and World Report (USNWR). Using a modified two-part model, we examined financial and operational characteristics (TAVR performance scores, median all-payer within-hospital TAVR price, net hospital profit margin, hospital markups [i.e., charge-to-cost ratio], bed days available, and CMS wage index) of 640 TAVR-performing hospitals ranked by the USNWR. After determining observed to expected (O:E) ratios for TAVR prices for each hospital, we then examined hospital characteristics across O:E quintiles. Overall, price disclosure was 48.6% (n=311). Between the lowest and highest O:E quintiles, median hospital markup (4.75 vs 5.33; p=0.41) and median net hospital margin (1.76 vs 3.15; p=0.12) were comparable. The highest O:E ratio quintile had lower median TAVR prices compared to the lowest O:E ratio quintile ($72,129.12 vs $49,022.03; p<0.001). Most significantly, TAVR price IQR’s within hospitals had a linear decline from the lowest to the highest O:E ratio quintiles ($119,043 vs $27,240; p<0.001). USNWR ranking scores had no significant variation across the quintiles (p=0.95). We concluded that hospitals that charge more than expected for TAVRs do not have higher profit margins nor markups and are not higher ranked by USNWR as those that charge less than expected. Additionally, with higher observed over expected TAVR prices, the variation in TAVR rates within hospitals decreased linearly. Finally, O:E TAVR price ratios appear to have no association with publicly reported hospital quality.

The authors have declared no competing interest.

Salary support for Dr Zhang was provided by the Veterans Affairs Office of Academic Affiliations through the VA/National Clinician Scholars Program and the School of Medicine at Duke University. Dr Cerullo was supported by funding via NIH/NCI T32CA093245. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government. The project was supported by the Duke Bass Connections grant. This manuscript has been accepted as a poster presentation at the 2022 AcademyHealth Annual Research Meeting on June 6th, 2022, in Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Funding: Bass Connections, Duke University

Disclaimers: No relationships with industry. This study has not been presented in part at a major research meeting prior to submission for publication. Salary support for Dr Zhang was provided by the Veterans Affairs Office of Academic Affiliations through the VA/National Clinician Scholars Program and the School of Medicine at Duke University. Dr Cerullo was supported by funding via NIH/NCI T32CA093245. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government. The project was supported by the Duke Bass Connections grant. This manuscript has been accepted as a poster presentation at the 2022 AcademyHealth Annual Research Meeting on June 6th, 2022, in Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

All data produced in the present study are available upon reasonable request to the authors.